Clinical Trials
3 trialsNCT05727176 2026-05-28
FOENIX-CCA4
Taiho Oncology, Inc.
Phase 2 Recruiting
NCT06506955 2026-05-28
Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
Taiho Oncology, Inc.
Phase 2/3 Enrolling by invitation
NCT02052778 2025-03-27
A Study of TAS-120 in Patients With Advanced Solid Tumors
Taiho Oncology, Inc.
Phase 1/2 Completed